Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Daniel Greiner
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States
Defne Bayik
Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Case Western Reserve University, Cleveland, United States
Dionysios C Watson
Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Case Western Reserve University, Cleveland, United States; University Hospitals Cleveland Medical Center, Cleveland, United States; School of Medicine, Case Western Reserve University, Cleveland, United States
Gregory S Olson
Medical Scientist Training Program, University of Washington, Seattle, United States
Justin D Lathia
Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Case Western Reserve University, Cleveland, United States
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States; Howard Hughes Medical Institute, University of Utah School of Medicine, Salt Lake City, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Alana L Welm
Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Thomas A Zangle
Department of Chemical Engineering, University of Utah, Salt Lake City, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Recent studies reveal that lateral mitochondrial transfer, the movement of mitochondria from one cell to another, can affect cellular and tissue homeostasis. Most of what we know about mitochondrial transfer stems from bulk cell studies and have led to the paradigm that functional transferred mitochondria restore bioenergetics and revitalize cellular functions to recipient cells with damaged or non-functional mitochondrial networks. However, we show that mitochondrial transfer also occurs between cells with functioning endogenous mitochondrial networks, but the mechanisms underlying how transferred mitochondria can promote such sustained behavioral reprogramming remain unclear. We report that unexpectedly, transferred macrophage mitochondria are dysfunctional and accumulate reactive oxygen species in recipient cancer cells. We further discovered that reactive oxygen species accumulation activates ERK signaling, promoting cancer cell proliferation. Pro-tumorigenic macrophages exhibit fragmented mitochondrial networks, leading to higher rates of mitochondrial transfer to cancer cells. Finally, we observe that macrophage mitochondrial transfer promotes tumor cell proliferation in vivo. Collectively these results indicate that transferred macrophage mitochondria activate downstream signaling pathways in a ROS-dependent manner in cancer cells, and provide a model of how sustained behavioral reprogramming can be mediated by a relatively small amount of transferred mitochondria in vitro and in vivo.